Cardiotoxicity and cytotoxicity of the anthracycline analog 4′-deoxy-4′-iodo-doxorubicin
- 31 December 1991
- journal article
- research article
- Published by Elsevier in Toxicology
- Vol. 70 (2) , 243-253
- https://doi.org/10.1016/0300-483x(91)90050-b
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Doxorubicin-Induced Cardiac ToxicityNew England Journal of Medicine, 1991
- Molecular mechanisms of drug resistanceBiochemical Journal, 1990
- Lack of cross-resistance of a doxorubicin-resistant B16 melanoma line with 4'-deoxy-4'-iodo-doxorubicinCancer Chemotherapy and Pharmacology, 1988
- A simple experimental index for the evaluation of inotropic responsesJournal of Pharmacological Methods, 1987
- Measurement of the SαT segment as the most reliable electrocardiogram parameter for the assessment of adriamycin-induced cardiotoxicity in the ratJournal of Pharmacological Methods, 1986
- Effects of chronic administration of doxorubicin on myocardial beta-adrenergec receptorsLife Sciences, 1986
- Might adriamycinol contribute to adrimycin-induced cardiotoxicity?Pharmacological Research Communications, 1985
- Effect of doxorubicin-enhanced hydrogen peroxide and hydroxyl radical formation on calcium sequestration by cardiac sarcoplasmic reticulumBiochemical and Biophysical Research Communications, 1985
- Cardiomyopathy of Doxorubicin in Experimental Animals. Factors Affecting the Severity, Distribution and Evolution of Myocardial LesionsTumori Journal, 1981
- Adriamycin: The Role of Lipid Peroxidation in Cardiac Toxicity and Tumor ResponseScience, 1977